Analysis of the regulatory framework to address the fentanyl crisisfrom an international perspective
DOI:
https://doi.org/10.18041/2215-8944/academia.30.12975Keywords:
Anti-drug, Drug trafficking, Drug control, Fentanyl, International securityAbstract
This study examines the limitations of Colombia's legal framework in addressing the growing fentanyl crisis and its consequences. Through a documentary review of national and international regulations, the primary legal gaps in confronting the illicit manufacture, trafficking, and consumption of fentanyl are identified. A qualitative approach based on documentary review and scientific literature was employed. The results conclude that the current legal framework has been insufficient in containing the problem, evidencing a gap between regulations and reality. The study argues for the need to strengthen the legal framework, implement prevention programs, closely monitor the evolution of the problem, and reinforce international cooperation to combat this phenomenon through effective information networks. This research contributes significantly to the understanding of the fentanyl problem in Colombia and provides valuable inputs to improve the legal and policy response to this transnational public health crisis.
References
Andrade, S. A., & Pibaque, M. C. (2024). La prevención y su incidencia en el consumo de drogas en adolescentes Distrito 10D02 2021-2022. Polo Del Conocimiento, 9(6), 381–398. https://doi.org/10.23857/pc.v9i6.7321
Bailey, K., Abramovitz, D., Artamonova, I., Davidson, P., Stamos-Buesig, T., Vera, C. F., Patterson, T. L., Arredondo, J., Kattan, J., Bergmann, L., Thihalolipavan, S., Strathdee, S. A., & Borquez, A. (2023). Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California. International Journal of Drug Policy, 118, 104086. https://doi.org/10.1016/j.drugpo.2023.104086
Barfidokht, A., Mishra, R. K., Seenivasan, R., Liu, S., Hubble, L. J., Wang, J., & Hall, D. A. (2019). Wearable electrochemical glove-based sensor for rapid and on-site detection of fentanyl. Sensors and Actuators B: Chemical, 296, 126422. https://doi.org/10.1016/j.snb.2019.04.053
Beletsky, L., & Davis, C. S. (2017). Today’s fentanyl crisis: Prohibition’s Iron Law, revisited. International Journal of Drug Policy, 46, 156–159. https://doi.org/10.1016/j.drugpo.2017.05.050
Bewley-Taylor, D., & Jelsma, M. (2012). Regime change: Re-visiting the 1961 Single Convention on Narcotic Drugs. International Journal of Drug Policy, 23(1), 72–81. https://doi.org/10.1016/j.drugpo.2011.08.003
Castaño, G. A., Calderón, G. A., & Berbesi, D. Y. (2013). Consumo de drogas emergentes en Medellín, Colombia. Revista Colombiana de Psiquiatría, 42(3), 248–256. https://doi.org/10.1016/S0034-7450(13)70017-9
Ciccarone, D. (2021). The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry, 34(4), 344–350. https://doi.org/10.1097/YCO.0000000000000717
Cogan, J. (2024). The United States Takes Actions to Combat International Fentanyl Trafficking. American Journal of International Law, 118(1), 183. https://link.gale.com/apps/doc/A784042419/HRCA?u=anon~49fd811c&sid=googleScholar&xid=0a837054
Collins, J., & Alarcón, K. T. (2021). Colombia, the Drug Wars and the Politics of Drug Policy Displacement – from La Violencia to UNGASS 2016. Journal of Illicit Economies and Development, 3(2), 190–205. https://doi.org/10.31389/jied.93
Comer, S. D., & Cahill, C. M. (2019). Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neuroscience & Biobehavioral Reviews, 106, 49–57. https://doi.org/10.1016/j.neubiorev.2018.12.005
Comisión Europea. (2022). Reglamento Delegado (UE) 2023/196 de la Comisión Europea. Diario Oficial de La Unión Europea. https://www.boe.es/doue/2023/027/L00001-00005.pdf
Congreso de Colombia. (2000). Ley 599 de 2000. Función Pública. https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=6388
Congreso de Colombia. (2004). Ley 906 de 2004. Función Pública. https://www.funcionpublica.gov.co/eva/gestornormativo/norma_pdf.php?i=14787
Congreso de la República. (1974). Ley 13 de 1974. Sistema Único de Información Normativa. https://www.cerlatam.com/wp-content/uploads/2021/07/LEY-13-DE-1974.pdf
Congreso de la República. (1986). Ley 30 de 1986. Función Pública. https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=2774
Congreso de la República. (1993). Ley 67 de 1993. Sistema Único de Información Normativa.
Congreso de la República. (1997). Ley 365 de 1997. Función Pública. https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=22771#0
Congreso de la República de Colombia. (2023). Proyecto de Ley No. 194 de 2023. Senado de La República. https://leyes.senado.gov.co/proyectos/index.php/textos-radicados-senado/pley-2023-2024/3088-proyecto-de-ley-194-de-2023
Consejo de la Unión Europea. (2022a). Decisión (UE) 2022/391 del Consejo de la Unión Europea. Diario Oficial de La Unión Europea. https://eur-lex.europa.eu/legal-content/ES/TXT/PDF/?uri=CELEX:32022D0391&from=ES
Consejo de la Unión Europea. (2022b). Decisión (UE) 2022/393 del Consejo de la Unión Europea. Diario Oficial de La Unión Europea. https://eur-lex.europa.eu/legal-content/ES/TXT/PDF/?uri=CELEX:32022D0393&from=ES
Consejo Nacional de Estupefacientes. (2015). Resolución No. 0001 de 2015. Consejo Nacional de Estupefacientes. https://www.minjusticia.gov.co/programas-co/control-para-el-manejo-sustancias-quimicas/Documents/normatividad/Resoluci%C3%B3n%200001%20del%208%20de%20Enero%20de%202015.pdf
Constitución Política. (1991). Constitución Política 1991. Corte Constitucional. https://www.corteconstitucional.gov.co/inicio/Constitucion-Politica-Colombia-1991.pdf
DEA. (2016). Counterfeit prescription pills containing fentanyls: a global threat. DEA Strategic Intelligence Section. https://www.dea.gov/sites/default/files/docs/Counterfeit%2520Prescription%2520Pills.pdf
Drug Enforcement Administration. (2022). Fentanyl Drug Fact Sheet. Drug Enforcement Administration. https://www.getsmartaboutdrugs.com
Egan, K. L., McCoy, T. P., Yassa, R., Daniel, J., Wagoner, K. G., Pankratz, M. M., Moore, J. B., Ross, J. C., Ballard, P. J., & Rhodes, S. D. (2024). Youth and young adult knowledge of and access to opioid harm reduction policies and interventions in North Carolina. Drug and Alcohol Dependence Reports, 12, 100265. https://doi.org/10.1016/j.dadr.2024.100265
Felbab-Brown, V. (2022). China and synthetic drugs control: Fentanyl, methamphetamines, and precursors. Policy Commons. https://coilink.org/20.500.12592/40f3zq
Fornili, K. S. (2019). International Control Efforts to Curb the Global Production and Trafficking of Fentanyl and Other Synthetic Opioids. Journal of Addictions Nursing, 30(1), 71–76. https://doi.org/10.1097/JAN.0000000000000269
Función Pública. (2018). Decreto 1844 de 2018. Función Pública. https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=88843
García, M., & Ortiz, A. M. (2014). Opiniones ciudadanas ante las políticas antidrogas en seis ciudades de América Latina. Análisis Político, 27(80), 27–52. https://doi.org/10.15446/anpol.v27n80.45613
Goldman, J. E., Waye, K. M., Periera, K. A., Krieger, M. S., Yedinak, J. L., & Marshall, B. D. L. (2019). Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduction Journal, 16(1), 3. https://doi.org/10.1186/s12954-018-0276-0
Gómez, Ó. E. (2019). Directrices de la política antidrogas en el marco de la acción de la Policía Nacional. Revista Logos, Ciencia & Tecnología, 12(1). https://doi.org/10.22335/rlct.v3i2.157
Gonzalez, R. U., Morales, J. I., & Rebollar, E. J. (2024). Revisión documental de fentanilo. Revista Mexicana de Ciencias Penales, 7(22), 29–48. https://doi.org/10.57042/rmcp.v7i22.657
Green, T. C., Park, J. N., Gilbert, M., McKenzie, M., Struth, E., Lucas, R., Clarke, W., & Sherman, S. G. (2020). An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. International Journal of Drug Policy, 77, 102661. https://doi.org/10.1016/j.drugpo.2020.102661
Hamilton, L., Davis, C. S., Kravitz-Wirtz, N., Ponicki, W., & Cerdá, M. (2021). Good Samaritan laws and overdose mortality in the United States in the fentanyl era. International Journal of Drug Policy, 97, 103294. https://doi.org/10.1016/j.drugpo.2021.103294
Han, Y., Yan, W., Zheng, Y., Khan, M. Z., Yuan, K., & Lu, L. (2019). The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Translational Psychiatry, 9(1), 282. https://doi.org/10.1038/s41398-019-0625-0
Hermans, S. P., Samiec, J., Golec, A., Trimble, C., Teater, J., & Hall, O. T. (2023). Years of Life Lost to Unintentional Drug Overdose Rapidly Rising in the Adolescent Population, 2016–2020. Journal of Adolescent Health, 72(3), 397–403. https://doi.org/10.1016/j.jadohealth.2022.07.004
Hernández, O., Espada, J. P., Orgilés, M., & García, J. M. (2013). Programa de prevención del consumo de drogas Saluda: evaluación de una nueva versión en adolescentes españoles. Health and Addictions/Salud y Drogas, 13(2), 135–144. https://doi.org/10.21134/haaj.v13i2.210
Hernando, C. (2023). El consumo de opiáceos y opioides en el mundo. El Orden Mundial En El Siglo XXI. https://elordenmundial.com/mapas-y-graficos/consumo-opiaceos-opioides-mundo/
Hill, R., Santhakumar, R., Dewey, W., Kelly, E., & Henderson, G. (2020). Fentanyl depression of respiration: Comparison with heroin and morphine. British Journal of Pharmacology, 177(2), 254–265. https://doi.org/10.1111/bph.14860
Jannetto, P. J., Helander, A., Garg, U., Janis, G. C., Goldberger, B., & Ketha, H. (2019). The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. Clinical Chemistry, 65(2), 242–253. https://doi.org/10.1373/clinchem.2017.281626
Kiyatkin, E. A. (2019). Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl. Neuropharmacology, 151, 219–226. https://doi.org/10.1016/j.neuropharm.2019.02.008
Lassi, N. (2023). Strengthening pill press control to combat fentanyl: Legislative and law enforcement imperatives. Exploratory Research in Clinical and Social Pharmacy, 11, 100321. https://doi.org/10.1016/j.rcsop.2023.100321
León, M. X., Sánchez-Cárdenas, M. A., Rodríguez-Campos, L. F., Moyano, J., López Velasco, A., Gamboa Garay, O., Buitrago, L., & De Lima, L. (2021). Availability and accessibility of opioids for pain and palliative care in Colombia: a survey study. Colombian Journal of Anesthesiology, 50(1). https://doi.org/10.5554/22562087.e1011
Lim, T. Y., Dong, H., Stringfellow, E., Hasgul, Z., Park, J., Glos, L., Kazemi, R., & Jalali, M. S. (2024). Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis. The Lancet Regional Health - Americas, 39, 100898. https://doi.org/10.1016/j.lana.2024.100898
López, D., Herrera, C., & González, S. (2024). El fentanilo desde el punto de vista criminológico. Quadernos de Criminología (Segunda Época), 1(1), 46–55. https://doi.org/10.5281/zenodo.10566737
Mars, S. G., Rosenblum, D., & Ciccarone, D. (2019). Illicit fentanyls in the opioid street market: desired or imposed? Addiction, 114(5), 774–780. https://doi.org/10.1111/add.14474
Meyer, M., Westenberg, J. N., Jang, K. L., Choi, F., Schreiter, S., Mathew, N., King, C., Lang, U. E., Vogel, M., & Krausz, R. M. (2023). Shifting drug markets in North America - a global crisis in the making? International Journal of Mental Health Systems, 17(1), 36. https://doi.org/10.1186/s13033-023-00601-x
Ministerio de Protección Social. (2006). Resolución No. 001478 de 2006. Ministerio de Protección Social. http://autorregulacion.saludcapital.gov.co/leyes/Resolucion_1478_de_2006.pdf
Ministerio de Salud y Protección Social. (2020). Resolución No. 0000315 de 2020. Ministerio de Salud y Protección Social. https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No.%200315%20de%202020.pdf
Naciones Unidas. (2021). Informe de la Junta Internacional de Fiscalización de Estupefacientes correspondiente a 2021. Junta Internacional de Fiscalización de Estupefacientes. https://www.incb.org/documents/Publications/AnnualReports/AR2021/Annual_Report/E_INCB_2021_1_spa.pdf
National Institute on Drug Abuse. (2021). Fentanyl DrugFacts. National Institute on Drug Abuse. https://nida.nih.gov/publications/drugfacts/fentanyl
Noriega, I., Bhullar, M. K., Gilson, T. P., Flannery, D. J., Deo, V., & Fulton, S. (2023). A case study for local data surveillance in opioid overdose fatalities in Cuyahoga County, OH 2016-2020. Drug and Alcohol Dependence Reports, 8, 100187. https://doi.org/10.1016/j.dadr.2023.100187
Núñez, M. A. (2014). Drug use and the right to health: An analysis of international law and the Mexican case. Mexican Law Review, 6(2), 201–224. https://doi.org/10.1016/S1870-0578(16)30012-9
Observatorio de drogas de Colombia. (2024). Situación actual de la problemática del fentanilo y opioides sintéticos con fines no médicos en Colombia. Ministerio de Justicia. https://www.minjusticia.gov.co/programas-co/ODC/Documents/Publicaciones/Fentanilo.pdf
Organización de las Naciones Unidas. (1961). Convención única de 1961 sobre estupefacientes. Organización de Las Naciones Unidas. https://www.incb.org/documents/NarcoticDrugs/1961-Convention/convention_1961_es.pdf
Organización de las Naciones Unidas. (1971). Convenio sobre sustancias sicotrópicas de 1971. Organización de Las Naciones Unidas. https://www.incb.org/documents/Psychotropics/trainingmaterials/2018/INCB_PSY_Training_SPA_V1804921.pdf
Organización de las Naciones Unidas. (1988). Convención de las Naciones Unidas contra el tráfico ilícito de estupefacientes y sustancias sicotrópicas 1988. Naciones Unidas. https://www.incb.org/documents/PRECURSORS/1988_CONVENTION/1988Convention_S.pdf
Pacurucu-Castillo, S. F., Ordóñez-Mancheno, J. M., Hernández-Cruz, A., & Alarcón, R. D. (2019). World Opioid and Substance Use Epidemic: A Latin American Perspective. Psychiatric Research and Clinical Practice, 1(1), 32–38. https://doi.org/10.1176/appi.prcp.20180009
Patocka, J., Wu, W., Oleksak, P., Jelinkova, R., Nepovimova, E., Spicanova, L., Springerova, P., Alomar, S., Long, M., & Kuca, K. (2024). Fentanyl and its derivatives: Pain-killers or man-killers? Heliyon, 10(8), e28795. https://doi.org/10.1016/j.heliyon.2024.e28795
Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019). Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. International Journal of Drug Policy, 63, 122–128. https://doi.org/10.1016/j.drugpo.2018.08.007
Pereira, P. J. dos R. (2021). Drugs, Violence, and Capitalism: The Expansion of Opioid Use in the Americas. Latin American Perspectives, 48(1), 184–201. https://doi.org/10.1177/0094582X20975007
Pérez, C., & Ibarrola, A. (2023). La transición hacia el fentanilo Cambios y continuidades del mercado de drogas en México (2015-2022). Revista de Ciencias Sociales, 36(53). https://doi.org/10.26489/rvs.v36i53.1
Ramírez-Telles, M., & Argotti-Rodríguez, U. (2022). Regulation of Drug Prescribing Information in Latin America and the Caribbean. Therapeutic Innovation & Regulatory Science, 56(4), 536–551. https://doi.org/10.1007/s43441-022-00396-y
Rejer, K. (2022). Fentanyl in the Global Market: Examining the New Opioid Epidemic at an International Level [University of San Diego]. https://doi.org/10.22371/02.2022.008
Savinkina, A., Jurecka, C., Gonsalves, G., & Barocas, J. A. (2023). Mortality, incarceration and cost implications of fentanyl felonization laws: A modeling study. International Journal of Drug Policy, 121, 104175. https://doi.org/10.1016/j.drugpo.2023.104175
Shaw, L. C., Biello, K. B., Buxton, J. A., Goldman, J. E., Hadland, S. E., Sherman, S. G., Li, Y., Macmadu, A., & Marshall, B. D. L. (2024). How substance use preferences and practices relate to fentanyl exposure among people who use drugs in Rhode Island, USA. Drug and Alcohol Dependence Reports, 12, 100280. https://doi.org/10.1016/j.dadr.2024.100280
Shover, C. L., Falasinnu, T. O., Dwyer, C. L., Santos, N. B., Cunningham, N. J., Freedman, R. B., Vest, N. A., & Humphreys, K. (2020). Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance. Drug and Alcohol Dependence, 216, 108314. https://doi.org/10.1016/j.drugalcdep.2020.108314
Soto, M. (2021). Fentanilo, el gran negocio del crimen organizado: implicaciones en el combate a las drogas. Revista De Relaciones Internacionales De La UNAM, 140, 89–116. https://www.revistas.unam.mx/index.php/rri/article/view/83040
Speed, K. A., Choi, J., Felicella, G., Sedgemore, K., Mok, W. Y., Milloy, M., DeBeck, K., Kerr, T., & Hayashi, K. (2024). Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada. International Journal of Drug Policy, 132, 104564. https://doi.org/10.1016/j.drugpo.2024.104564
Tobias, S., Ferguson, M., Palis, H., Burmeister, C., McDougall, J., Liu, L., Graham, B., Ti, L., & Buxton, J. A. (2024). Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study. International Journal of Drug Policy, 123, 104290. https://doi.org/10.1016/j.drugpo.2023.104290
Torralva, R., & Janowsky, A. (2019). Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis. Journal of Pharmacology and Experimental Therapeutics, 371(2), 453–475. https://doi.org/10.1124/jpet.119.258566
Volpe, D. A., Tobin, G. A. M., Mellon, R. D., Katki, A. G., Parker, R. J., Colatsky, T., Kropp, T. J., & Verbois, S. L. (2011). Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs. Regulatory Toxicology and Pharmacology, 59(3), 385–390. https://doi.org/10.1016/j.yrtph.2010.12.007
Wang, C., Lassi, N., Zhang, X., & Sharma, V. (2022). The Evolving Regulatory Landscape for Fentanyl: China, India, and Global Drug Governance. International Journal of Environmental Research and Public Health, 19(4), 2074. https://doi.org/10.3390/ijerph19042074
Wilde, M., Pichini, S., Pacifici, R., Tagliabracci, A., Busardò, F. P., Auwärter, V., & Solimini, R. (2019). Metabolic Pathways and Potencies of New Fentanyl Analogs. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.00238
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Academia & Derecho
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
